Hidden Liver Fibrosis Found in 1.6% of European Adults in Massive Screening Study
Largest European study reveals widespread undiagnosed liver fibrosis, primarily linked to metabolic factors and alcohol use.
Summary
The LiverScreen project screened over 30,000 adults across nine European countries and found that 1.6% had undiagnosed chronic liver disease with fibrosis. Using liver stiffness measurements, researchers identified that 4.6% had elevated liver stiffness, with metabolic factors like obesity and diabetes being the primary drivers. Most cases (93%) were steatotic liver disease, highlighting the growing burden of fatty liver disease in the general population.
Detailed Summary
This groundbreaking study addresses a critical gap in understanding liver disease burden across Europe. While liver fibrosis can progress silently to cirrhosis and liver failure, its true prevalence in the general population remained unclear until now.
The LiverScreen consortium enrolled 30,199 adults aged 40+ from 35 sites across nine European countries. Participants underwent liver stiffness measurement using vibration-controlled transient elastography, with values ≥8 kPa indicating potential fibrosis. Those with positive screens were referred for hepatology evaluation.
Key results showed 4.6% had elevated liver stiffness, and after clinical confirmation, 1.6% had chronic liver disease with fibrosis. Steatotic liver disease (fatty liver) accounted for 93% of cases. Strong associations emerged with obesity, type 2 diabetes, and harmful alcohol consumption, affecting 70% of participants for metabolic factors and 6.1% for harmful drinking.
These findings reveal that liver fibrosis is far more common than previously recognized, with metabolic dysfunction being the dominant cause. Early detection could enable lifestyle interventions and medical treatments to prevent progression to cirrhosis. However, the study's reliance on elastography rather than biopsy may affect diagnostic precision, and the European population may not represent global patterns.
Key Findings
- 1.6% of European adults have undiagnosed chronic liver disease with fibrosis
- 4.6% show elevated liver stiffness suggesting early fibrosis
- 93% of confirmed cases are steatotic liver disease (fatty liver)
- Strong links to obesity, diabetes, and harmful alcohol consumption
- Only 61% of referred patients completed hepatology evaluation
Methodology
Multinational cohort study across 35 sites in nine European countries using vibration-controlled transient elastography for liver stiffness measurement. Positive screens (≥8 kPa or elevated ALT) were referred for hepatology confirmation.
Study Limitations
Summary based on abstract only. Diagnostic confirmation relied on clinical evaluation rather than liver biopsy. Low completion rate (61%) for hepatology referrals may affect prevalence estimates. European population may not represent global patterns.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.